HB 670 would protect access to abortion clinics in Pennsylvania by creating a legal right for people to enter reproductive health services facilities and allowing lawsuits against individuals or entities that block access. It amends criminal and judicial statutes to define "blocking access" as a violation and imposes penalties for such actions. The bill directly affects patients seeking abortion care, clinic staff, and anyone attempting to obstruct facility access. Key provisions include enabling civil lawsuits for damages and establishing specific criminal penalties for interference with facility access.
HB 348 amends Pennsylvania's Human Services Code to require the state human services department to notify medical assistance applicants about their right to legal representation during application or eligibility reviews. This change directly affects individuals applying for medical assistance programs (like Medicaid) and the department responsible for processing these applications. The key provision mandates that applicants receive written notice detailing their option to seek legal help, which the department must provide before finalizing eligibility decisions. The bill focuses on improving transparency in the application process without altering eligibility criteria or benefit amounts.
HB 1881 updates Pennsylvania's Pharmacy Act to modernize requirements for pharmacy technicians and trainees, including new registration qualifications and supervision rules by licensed pharmacists. It adds specific protocols for pharmacies administering injectable medications, biologicals (like vaccines), and immunizations, while requiring detailed reports on vaccine administration. The bill also establishes new standards for clinical laboratory certificates and repeals outdated sections of the original 1961 law. These changes directly affect pharmacies, pharmacy technicians, trainees, and pharmacists who oversee vaccine and medication administration.
HB 1530, the Genetic Information Privacy Act, requires direct-to-consumer genetic testing companies operating in Pennsylvania to protect residents' genetic data. Companies must obtain clear, separate consent for data collection, use, sharing, and retention; implement security measures; and provide consumers with access to or deletion of their data. The bill specifically prohibits sharing genetic data with insurers, employers, or third parties without explicit written consent. Violations could result in $2,500 civil penalties per incident, enforced by the Attorney General’s office. The law applies to Pennsylvania residents and covers genetic data like DNA test results, but excludes research data collected under federal health privacy rules.
This Pennsylvania House resolution (HR 382) urges Congress to extend expanded health insurance subsidies that currently help Pennsylvanians purchase coverage through Pennie, the state's health insurance marketplace. Without extension, these subsidies expire December 31, 2025, causing average premium increases of 102% for Pennie customers - projected to push 150,000 people to lose coverage. The resolution highlights that without the expanded credits, a couple earning $85,000 annually would pay $25,776 yearly for insurance (31% of their income), compared to lower costs under current subsidies. It cites Pennie's 2025 enrollment of nearly 500,000 customers and a 16% drop in new sign-ups since Open Enrollment 2026 as evidence of the need for continued support. The resolution has no legal force but requests congressional action to maintain affordability.
HB 1202 establishes Pennsylvania's Infectious Disease Advisory Commission to coordinate long-term responses to public health emergencies like pandemics. The bill requires the Governor to select a statewide organization via competitive bidding to manage a PPE stockpile, including sourcing from in-state manufacturers and maintaining four designated storage locations. It directly affects healthcare facilities (such as nursing homes, assisted living centers, and personal care homes) by mandating infectious disease plans and requiring facilities to designate coordinators for outbreak response. Key provisions include creating the Commission, defining emergency protocols, and ensuring PPE availability during health crises. The law focuses on systemic preparedness rather than specific pandemic responses.
HB 923 amends the State Lottery Law to redirect lottery revenue toward providing pharmaceutical assistance for elderly residents. It directly affects seniors who qualify for prescription drug aid under state programs by modifying eligibility determination procedures. The key provision updates how income and asset thresholds are calculated to determine who qualifies for this assistance. The bill became law on November 24, 2025, after approval by both legislative chambers and the governor.
SB 88 amends Pennsylvania's Insurance Company Law to require health insurance plans sold in the state to cover specific breast imaging services without cost-sharing for policyholders. It mandates annual mammograms for women 40+ and physician-recommended mammograms for women under 40, plus MRI and other breast imaging for those at average or higher risk of breast cancer due to factors like family history, genetic mutations, or dense breast tissue. The law specifies coverage for screening, supplemental, and diagnostic exams but does not require coverage for mastectomies or override standard deductibles/copays beyond the minimum required services. This replaces prior requirements that allowed cost-sharing and excluded MRI coverage.
The bill (HB 1715) amends Pennsylvania's Newborn Child Testing Act to enhance newborn screening and follow-up programs. It directly affects newborns, parents, and healthcare providers by updating requirements for screening tests and ensuring timely medical follow-up for infants with positive results. The bill's key provisions focus on improving the accuracy and efficiency of the screening process and strengthening coordination between healthcare facilities and public health agencies. As currently described in the provided context, the bill's specific policy changes beyond the title are not detailed. It is pending in the Health committee after being laid on the table.
HB 1652 adds Gaucher disease to Pennsylvania's mandatory newborn screening program under the Newborn Child Testing Act. The bill expands the existing program to require screening for this genetic disorder in newborns, directly affecting all infants born in Pennsylvania. Key provisions include updating the list of covered conditions under Section 3(a)(1) of the 1965 Act, ensuring healthcare providers screen for Gaucher disease to identify it early. This change aims to enable timely treatment to prevent intellectual or physical disabilities, aligning with the program's existing purpose. The bill does not alter funding or implementation processes, only adding one specific condition to the screening list.
